| Issue Date | 16 Dec 2021 - 20 Dec 2021 |
| Issue Size | ₹700.00 Cr |
| Issue Price | ₹265-274 |
| Market Lot | 54 Shares |
| Shares on Offer | |
| Registrar | Link Intime |
| GMP | ₹120-125 |
| Kostak | ₹250 |
| Subject to Sauda | ₹7000 |
| Listing Date | 28 Dec 2021 |
| Listing Price | ₹425 |
| Listing Gain% | 55.11 |
Supriya Lifescience Ltd. has well-established presence in API Manufacturing with focus on products in various therapeutic segments like – Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics, Anti-Asthmatics etc.
Supriya Lifescience Ltd. takes pride in setting the products, processes and the systems as per the industry standards and in making continous improvement to deliver quality products. Our facility is spread across an area of 47000 sq.m. with delineated areas for warehouse, QA, QC, R & D, production and finished products (dedicated blocks for different therapeutic segments). The plant has current capacity of 550 KL and supported with multiple clean rooms for finished products. As a part of our capacity expansion plan, our capacity would be approximately 1000+ KL by 2024.
Supriya Lifescience Ltd. is backed by strong R&D, 14 active USDMFs, 8 active CEPs & World wide compliant facilities (EMA, US FDA, WHO, PMDA, TGA, KFDA, ANVISA). Core business is driven by Ethical values and EHS standards. Our focus is to develop APIs and Intermediates for both Innovators, Generic companies and we also partner exclusively as CMO.
Satish Waman Wagh is the company promoter.
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Total Assets (In ₹ Millions) | 4,458.24 | 3,364.01 | 2,530.52 |
| Total Revenue (In ₹ Millions) | 3,962.21 | 3,227.13 | 2,858.62 |
| Profit After Tax (PAT) (In ₹ Millions) | 1,238.28 | 733.74 | 394.24 |
| Date | GMP | Kostak | Subject to Sauda |
|---|---|---|---|
| 21 Dec 2021 | ₹120-125 | ₹250 | ₹7000 |
| 18 Dec 2021 | ₹290-295 | N/A | N/A |
| 16 Dec 2021 | ₹270-275 | N/A | N/A |
| 15 Dec 2021 | ₹240-250 | N/A | N/A |
| Strength |
|---|
| Weakness |
|---|
| Date & Time | QIB | NII | RII | Total |
|---|---|---|---|---|
| Day 1 - 16 Dec 2021 | 0.00 | 0.66 | 11.84 | 2.33 |
| Day 2 - 17 Dec 2021 | 0.53 | 2.90 | 25.38 | 5.69 |
| Day 3 - 20 Dec 2021 | 31.83 | 161.22 | 56.01 | 71.51 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusSupriya Lifescience Limited IPO will open on 16 Dec 2021 and close on 20 Dec 2021.
Supriya Lifescience Limited IPO will list on 28 Dec 2021.
The offer price of Supriya Lifescience Limited IPO is ₹265-274.
The lot size of Supriya Lifescience Limited IPO is 54.
The Grey Market Premium (GMP) price of Supriya Lifescience Limited IPO is ₹120-125.
The Kostak price of Supriya Lifescience Limited IPO is ₹250.
The Subject to Sauda price for Supriya Lifescience Limited IPO is ₹7000.
Please Leave Your Message
Supriya Lifescience Limited IPO Review/Comments